General Information
Drug ID
DR00557
Drug Name
Hesperetin
Synonyms
(-)-hesperetin; (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-2,3-dihydro-4H-chromen-4-one; (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-2,3-dihydrochromen-4-one; (S)-2,3-Dihydro-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-benzopyrone; (S)-2,3-dihydro-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one; 3',5,7-Trihydroxy-4'-methoxyflavanone; 3',5,7-Trihydroxy-4-methoxyflavanone; 4H-1-Benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-, (S)-(9CI); 5,7,3'-Trihydroxy-4'-methoxyflavanone; Cyanidanon 4'-methyl ether 1626; Flavanone, 3',5,7-trihydroxy-4'-methoxy-(VAN); Flavanone, 3',5,7-trihydroxy-4'-methoxy-(VAN) (8CI); Hesperin; Hesperitin; TNP00238; YSO2
Drug Type
Small molecular drug
Indication High cholesterol level [ICD11: 5C80.00] Approved [1]
Therapeutic Class
Anticholesteremic Agents
Structure
3D MOL 2D MOL
Formula
C16H14O6
Canonical SMILES
COC1=C(C=C(C=C1)C2CC(=O)C3=C(C=C(C=C3O2)O)O)O
InChI
InChI=1S/C16H14O6/c1-21-13-3-2-8(4-10(13)18)14-7-12(20)16-11(19)5-9(17)6-15(16)22-14/h2-6,14,17-19H,7H2,1H3/t14-/m0/s1
InChIKey
AIONOLUJZLIMTK-AWEZNQCLSA-N
CAS Number
CAS 520-33-2
Pharmaceutical Properties Molecular Weight 302.28 Topological Polar Surface Area 96.2
Heavy Atom Count 22 Rotatable Bond Count 2
Hydrogen Bond Donor Count 3 Hydrogen Bond Acceptor Count 6
XLogP
2.4
PubChem CID
72281
PubChem SID
10321847 , 11112384 , 11112385 , 11336214 , 11361453 , 11363075 , 11365637 , 11368199 , 11372127 , 11375448 , 11376361 , 11462425 , 11466152 , 11467272 , 11485481 , 11485843 , 11489609 , 11490919 , 11493749 , 11493995 , 11537620 , 16889621 , 24895619 , 26613332 , 26680108 , 26744164 , 26754195 , 26754196 , 29204220 , 43128472 , 46507998 , 47365297 , 47365298 , 47440361 , 47515405 , 47515406 , 47885508 , 47959861 , 48035231 , 48110539 , 48259342 , 48421825 , 4847 , 49698360 , 50069543 , 50091682 , 597194 , 8149172 , 8195111 , 877412
ChEBI ID
ChEBI:28230
TTD Drug ID
D07MGA
DT(s) Transporting This Drug BCRP Transporter Info Breast cancer resistance protein Substrate [2]
References
1 Drug information of Hesperetin, 2008. eduDrugs.
2 Interaction of the breast cancer resistance protein with plant polyphenols. Biochem Biophys Res Commun. 2004 Apr 23;317(1):269-75.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.